Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS

KOSPI

5,383.80

-300.00 (-5.28%)

KOSDAQ

678.41

-36.54 (-5.11%)

KOSPI 200

837.78

-51.47 (-5.79%)

USD/KRW

1,342.10

Home›Reports›069620

069620KOSPI·Nov 10, 2025

Compelling valuation

DAEWOONG PHARMAMirae Asset SecuritiesSeung-min Kim

Read original PDF ↗

Source: Mirae Asset Securities
Type: Company Analysis
Language: English
Rating: Buy
Target price: -
Collected: May 06, 2026

The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 069620

Early Nabota shipments lift earningsMirae Asset Securities · Jul 31, 2026 Initiating Coverage: New Business Potential; Discount to NarrowKB Securities · May 27, 2026 Efforts to streamline prescription drug channels underwayMirae Asset Securities · May 14, 2026 Strong margin growthMirae Asset Securities · Feb 11, 2025

Advertisement

Korean Tickers·Research reference for Korean listed companies.

Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.

KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources

Terms Refunds Disclaimer Privacy